Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Hampig Raphael Kourie,1 Elie El Rassy,1 Florian Clatot,2,3 Evandro de Azambuja,4 Matteo Lambertini3,4 1Department of Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon; 2Department of Medical Oncology and IRON/U1245, Centre Henri Becquerel, Rouen, France; 3Breast Cancer Transla...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kourie HR, El Rassy E, Clatot F, de Azambuja E, Lambertini M
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2017-07-01
Colecção:OncoTargets and Therapy
Assuntos:
Breast cancer
HER2-positive
neratinib
early-stage
targeted therapy.
Acesso em linha:https://www.dovepress.com/emerging-treatments-for-her2-positive-early-stage-breast-cancer-focus--peer-reviewed-article-OTT
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados